Characterisation of neuroprotective efficacy of modified poly-arginine-9 (R9) peptides using a neuronal glutamic acid excitotoxicity model
Crossref DOI link: https://doi.org/10.1007/s11010-016-2882-z
Published Online: 2016-11-14
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Edwards, Adam B.
Anderton, Ryan S.
Knuckey, Neville W.
Meloni, Bruno P.
License valid from 2016-11-14